Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

Clinical trial NCT03823911 · COMPLETED

Trial details

NCT number: NCT03823911
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiovascular Diseases Hepatitis C Hiv

Start date: 2018-11-18
Primary completion: 2022-12-31
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.